Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
Crossref DOI link: https://doi.org/10.1038/srep31578
Published Online: 2016-08-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mold, Matthew
Shardlow, Emma
Exley, Christopher
Text and Data Mining valid from 2016-08-12
Version of Record valid from 2016-08-12
Article History
Received: 18 May 2016
Accepted: 26 July 2016
First Online: 12 August 2016
Competing interests
: The authors declare no competing financial interests.